US 12281327
Lymphohematopoietic engineering using CAS9 base editors
granted A61KA61K40/11A61K40/31
Quick answer
US patent 12281327 (Lymphohematopoietic engineering using CAS9 base editors) held by Regents of the University of Minnesota expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/4211, A61P